YMC – The Future of Gene Therapy Manufacturing: Focus on Innovative Purification Solutions

New Targets in the Spotlight: AAVs, VLPs and pDNA

In the world of biotechnology and pharmaceutical industry, the effective and reliable purification of complex biomolecules used for gene therapy is of crucial importance. In particular, the isolation of adeno-associated viruses (AAVs), virus-like particles (VLPs), and also plasmid DNA (pDNA) places high demands on the chromatography technologies used. As the demand for gene therapies grows, so does the need for highly specialised solutions which provide the precise purification of native and intact molecules ensuring the safety and efficacy of such therapeutics.